CD4 and pulmonary fibrosis: We conclude that CD4<sup>+</sup> T<sub>RM</sub> cells are pathogenic drivers in pulmonary fibrosis, originating from circulating precursors and being regulated by Notch signaling, underscoring their relevance for therapeutic intervention.